These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9224532)
21. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Cooper PN; Jackson M; Lennox G; Lowe J; Mann DM Arch Neurol; 1995 Oct; 52(10):1011-5. PubMed ID: 7575218 [TBL] [Abstract][Full Text] [Related]
22. [Clinico-pathological investigation of two patients with dementia with motor neuron disease]. Yamamoto R; Iseki E; Murayama N; Minegishi M; Kimura M; Eto K; Arai H; Ohbu S; Hatanaka D; Hino H; Fujisawa K Brain Nerve; 2007 Mar; 59(3):263-9. PubMed ID: 17370652 [TBL] [Abstract][Full Text] [Related]
23. Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3). Yancopoulou D; Crowther RA; Chakrabarti L; Gydesen S; Brown JM; Spillantini MG J Neuropathol Exp Neurol; 2003 Aug; 62(8):878-82. PubMed ID: 14503643 [TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. Okamoto K; Murakami N; Kusaka H; Yoshida M; Hashizume Y; Nakazato Y; Matsubara E; Hirai S J Neurol; 1992 Oct; 239(8):426-30. PubMed ID: 1333007 [TBL] [Abstract][Full Text] [Related]
25. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Tan CF; Kakita A; Piao YS; Kikugawa K; Endo K; Tanaka M; Okamoto K; Takahashi H Acta Neuropathol; 2003 Jun; 105(6):615-20. PubMed ID: 12734667 [TBL] [Abstract][Full Text] [Related]
35. Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia. Toyoshima Y; Piao YS; Tan CF; Morita M; Tanaka M; Oyanagi K; Okamoto K; Takahashi H Acta Neuropathol; 2003 Jul; 106(1):50-6. PubMed ID: 12669241 [TBL] [Abstract][Full Text] [Related]
36. Frontotemporal dementia: a clinical-pathological study. Michotte A; Goldman S; Tugendhaft P; Zegers de Beyl D Acta Neurol Belg; 2001 Dec; 101(4):224-9. PubMed ID: 11851030 [TBL] [Abstract][Full Text] [Related]
37. The neuropathology and biochemistry of frontotemporal dementia. Munoz DG; Dickson DW; Bergeron C; Mackenzie IR; Delacourte A; Zhukareva V Ann Neurol; 2003; 54 Suppl 5():S24-8. PubMed ID: 12833365 [No Abstract] [Full Text] [Related]
38. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM; Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875 [TBL] [Abstract][Full Text] [Related]
40. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Sampathu DM; Neumann M; Kwong LK; Chou TT; Micsenyi M; Truax A; Bruce J; Grossman M; Trojanowski JQ; Lee VM Am J Pathol; 2006 Oct; 169(4):1343-52. PubMed ID: 17003490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]